Business News

Professional Services News

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2018 After Market Close on July 16, 2018

TUSTIN, Calif., July 09, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to [...]

Avid Bioservices Added to Russell 3000® Index and Russell 2000® Index

TUSTIN, Calif., June 25, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) [...]

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

TUSTIN, Calif., June 06, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) [...]

Avid Bioservices to Participate at BIO International Convention 2018

– Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity [...]

Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences

– Addition of Senior Executive with Significant Process Science Experience Supports Company’s Efforts to Expand and Enhance Process Development Capabilities – TUSTIN, Calif., [...]

Savara to Host First Quarter 2018 Financial Results and Business Update Conference Call on Wednesday, May 9, 2018

AUSTIN, TX–(Marketwired – May 01, 2018) – Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced it will release its first quarter 2018 financial results on [...]

Pieris Pharmaceuticals to Host First Quarter 2018 Investor Call and Corporate Update on May 10, 2018

BOSTON, MA–(Marketwired – May 01, 2018) – Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary [...]

NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018

FT. MYERS, FL–(Marketwired – May 01, 2018) – NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the [...]

VIVUS Strengthens Executive Leadership Team

CAMPBELL, CA–(Marketwired – April 30, 2018) – VIVUS,Inc. (NASDAQ: VVUS) (the “Company”), a biopharmaceutical company, today announced the addition of three [...]

Oryzon to present at upcoming international conferences

MADRID, SPAIN and CAMBRIDGE, MA–(Marketwired – April 27, 2018) – 13th Annual Neurotech Investing & Partnering Conference in Boston, USA BioEquity Europe 2018 in Ghent, [...]

page  2  of  41